" We are determined to keep our position among leading pharmaceutical companies in Iran, however, our strategy aims to increase collaborations with abroad companies. Besides, we trust on our R&D teams to help us enter new scientific boundaries. "
on sustainability "Developing new medicines and tests is our main contribution to society."
commits to flexibility at the workplace and empowers people to deliver meaningful outcomes with balance.
The story ofunderscores our longstanding commitment to creating a partnership between business and science that improves people’s lives.
Innovating for patients
Providing a great workplace
Being a trustworthy partner
Environment and communities
Delivering continuous growth
30 patients
treated with medicines
>10000 tests
conducted with Diagnostics products
medicines
on the WHO Model List of Essential Medicines
72% employee engagement rate
30% of women
in key leadership positions
22% of key leaders
with diverse work experience
in Diagnostics in 2018
6 new partnerships
in Pharmaceuticals in 2018
100%
of approximately 200 business-critical suppliers risk-assessed
13% decrease
in water consumption since 2015
10% decrease
in energy consumption since 2015
23% improvement
in the eco-balance since 2014
+7% in Group sales
+9% in core operating profit
10 years in a row